HEADER PEPTIDE BINDING PROTEIN 23-SEP-22 8B5P TITLE TERNARY STRUCTURE OF 14-3-3S, ERRG PHOSPHOPEPTIDE AND DUAL-REACTIVE TITLE 2 COMPOUND 10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN SIGMA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EPITHELIAL CELL MARKER PROTEIN 1,STRATIFIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: GAMGS AT THE BEGINNING (-5 TO -1) ARE PART OF THE COMPND 8 EXPRESSION TAG; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ESTROGEN RELATED RECEPTOR GAMMA PHOSPHOPEPTIDE; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SFN, HME1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS 14-3-3, HUB-PROTEIN, DUAL-REACTIVE COMPOUND, PEPTIDE BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.A.SOMSEN,C.OTTMANN REVDAT 3 07-FEB-24 8B5P 1 REMARK REVDAT 2 05-APR-23 8B5P 1 JRNL REVDAT 1 29-MAR-23 8B5P 0 JRNL AUTH B.A.SOMSEN,R.J.C.SCHELLEKENS,C.J.A.VERHOEF,M.R.ARKIN, JRNL AUTH 2 C.OTTMANN,P.J.COSSAR,L.BRUNSVELD JRNL TITL REVERSIBLE DUAL-COVALENT MOLECULAR LOCKING OF THE 14-3-3/ERR JRNL TITL 2 GAMMA PROTEIN-PROTEIN INTERACTION AS A MOLECULAR GLUE DRUG JRNL TITL 3 DISCOVERY APPROACH. JRNL REF J.AM.CHEM.SOC. V. 145 6741 2023 JRNL REFN ESSN 1520-5126 JRNL PMID 36926879 JRNL DOI 10.1021/JACS.2C12781 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 56711 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.185 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 5474 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.5100 - 4.3500 1.00 3464 193 0.1726 0.1857 REMARK 3 2 4.3500 - 3.4500 0.99 3454 174 0.1546 0.1599 REMARK 3 3 3.4500 - 3.0200 1.00 3473 196 0.1698 0.1967 REMARK 3 4 3.0200 - 2.7400 1.00 3508 166 0.1741 0.1681 REMARK 3 5 2.7400 - 2.5500 1.00 3484 203 0.1771 0.2082 REMARK 3 6 2.5500 - 2.4000 1.00 3453 171 0.1711 0.1788 REMARK 3 7 2.4000 - 2.2800 1.00 3502 169 0.1609 0.1839 REMARK 3 8 2.2800 - 2.1800 0.99 3438 173 0.1602 0.1920 REMARK 3 9 2.1800 - 2.0900 1.00 3508 185 0.1596 0.1625 REMARK 3 10 2.0900 - 2.0200 1.00 3450 208 0.1556 0.1787 REMARK 3 11 2.0200 - 1.9600 1.00 3466 206 0.1722 0.1923 REMARK 3 12 1.9600 - 1.9000 1.00 3470 192 0.1692 0.1899 REMARK 3 13 1.9000 - 1.8500 1.00 3457 195 0.1754 0.1686 REMARK 3 14 1.8500 - 1.8100 1.00 3480 182 0.1772 0.1757 REMARK 3 15 1.8100 - 1.7700 1.00 3432 191 0.1854 0.2046 REMARK 3 16 1.7600 - 1.7300 1.00 3486 190 0.1855 0.1855 REMARK 3 17 1.7300 - 1.6900 1.00 3473 162 0.1715 0.1916 REMARK 3 18 1.6900 - 1.6600 1.00 3484 171 0.1698 0.1804 REMARK 3 19 1.6600 - 1.6300 1.00 3546 163 0.1656 0.1953 REMARK 3 20 1.6300 - 1.6000 0.99 3419 189 0.1723 0.1848 REMARK 3 21 1.6000 - 1.5800 0.99 3432 189 0.1666 0.1757 REMARK 3 22 1.5800 - 1.5500 1.00 3500 174 0.1721 0.1834 REMARK 3 23 1.5500 - 1.5300 0.99 3432 177 0.1741 0.2194 REMARK 3 24 1.5300 - 1.5100 0.99 3397 179 0.1772 0.1839 REMARK 3 25 1.5100 - 1.4900 0.99 3448 177 0.1740 0.1859 REMARK 3 26 1.4900 - 1.4700 0.99 3490 178 0.1729 0.1619 REMARK 3 27 1.4700 - 1.4500 0.98 3381 145 0.1804 0.1983 REMARK 3 28 1.4500 - 1.4300 0.98 3420 214 0.1943 0.2144 REMARK 3 29 1.4300 - 1.4200 0.98 3359 165 0.2088 0.2004 REMARK 3 30 1.4200 - 1.4000 0.96 3353 197 0.2393 0.2797 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8B5P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1292125810. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56735 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 45.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 13.40 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 33.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.43 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 6Y1D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.095 M HEPES PH 7.1, 0.19 M CACL2, REMARK 280 25% PEG400, 5% GLYCEROL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.26050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.26050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 41.23500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.92200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 41.23500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.92200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 31.26050 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 41.23500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.92200 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 31.26050 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 41.23500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.92200 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -61.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 404 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 174 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 68 CD CE NZ REMARK 470 GLU A 72 CG CD OE1 OE2 REMARK 470 SER A 74 OG REMARK 470 GLU A 76 CG CD OE1 OE2 REMARK 470 LYS A 77 CG CD CE NZ REMARK 470 ASP A 138 CG OD1 OD2 REMARK 470 ASP A 139 CG OD1 OD2 REMARK 470 LYS A 160 CD CE NZ REMARK 470 LYS A 214 CD CE NZ REMARK 470 ARG B 175 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 18 76.29 -102.20 REMARK 500 HIS A 106 35.99 -143.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 734 DISTANCE = 5.88 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 303 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 35 OE1 REMARK 620 2 GLU A 35 OE2 51.5 REMARK 620 3 GLU A 110 O 83.5 88.0 REMARK 620 4 GLU A 188 OE2 85.1 122.1 45.8 REMARK 620 5 HOH A 495 O 141.9 162.1 104.0 75.3 REMARK 620 6 HOH A 616 O 90.1 83.0 170.9 140.3 85.0 REMARK 620 7 HOH A 617 O 132.0 81.8 84.8 117.4 86.0 94.7 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 75 OE2 REMARK 620 2 GLU A 161 O 79.1 REMARK 620 3 HOH A 476 O 79.3 2.9 REMARK 620 4 HOH A 513 O 78.4 0.8 3.3 REMARK 620 5 HOH A 598 O 76.9 2.6 2.8 2.2 REMARK 620 N 1 2 3 4 DBREF 8B5P A 1 231 UNP P31947 1433S_HUMAN 1 231 DBREF 8B5P B 174 183 PDB 8B5P 8B5P 174 183 SEQADV 8B5P GLY A -4 UNP P31947 EXPRESSION TAG SEQADV 8B5P ALA A -3 UNP P31947 EXPRESSION TAG SEQADV 8B5P MET A -2 UNP P31947 EXPRESSION TAG SEQADV 8B5P GLY A -1 UNP P31947 EXPRESSION TAG SEQADV 8B5P SER A 0 UNP P31947 EXPRESSION TAG SEQADV 8B5P ASN A 38 UNP P31947 CYS 38 ENGINEERED MUTATION SEQRES 1 A 236 GLY ALA MET GLY SER MET GLU ARG ALA SER LEU ILE GLN SEQRES 2 A 236 LYS ALA LYS LEU ALA GLU GLN ALA GLU ARG TYR GLU ASP SEQRES 3 A 236 MET ALA ALA PHE MET LYS GLY ALA VAL GLU LYS GLY GLU SEQRES 4 A 236 GLU LEU SER ASN GLU GLU ARG ASN LEU LEU SER VAL ALA SEQRES 5 A 236 TYR LYS ASN VAL VAL GLY GLY GLN ARG ALA ALA TRP ARG SEQRES 6 A 236 VAL LEU SER SER ILE GLU GLN LYS SER ASN GLU GLU GLY SEQRES 7 A 236 SER GLU GLU LYS GLY PRO GLU VAL ARG GLU TYR ARG GLU SEQRES 8 A 236 LYS VAL GLU THR GLU LEU GLN GLY VAL CYS ASP THR VAL SEQRES 9 A 236 LEU GLY LEU LEU ASP SER HIS LEU ILE LYS GLU ALA GLY SEQRES 10 A 236 ASP ALA GLU SER ARG VAL PHE TYR LEU LYS MET LYS GLY SEQRES 11 A 236 ASP TYR TYR ARG TYR LEU ALA GLU VAL ALA THR GLY ASP SEQRES 12 A 236 ASP LYS LYS ARG ILE ILE ASP SER ALA ARG SER ALA TYR SEQRES 13 A 236 GLN GLU ALA MET ASP ILE SER LYS LYS GLU MET PRO PRO SEQRES 14 A 236 THR ASN PRO ILE ARG LEU GLY LEU ALA LEU ASN PHE SER SEQRES 15 A 236 VAL PHE HIS TYR GLU ILE ALA ASN SER PRO GLU GLU ALA SEQRES 16 A 236 ILE SER LEU ALA LYS THR THR PHE ASP GLU ALA MET ALA SEQRES 17 A 236 ASP LEU HIS THR LEU SER GLU ASP SER TYR LYS ASP SER SEQRES 18 A 236 THR LEU ILE MET GLN LEU LEU ARG ASP ASN LEU THR LEU SEQRES 19 A 236 TRP THR SEQRES 1 B 10 LYS ARG ARG ARG LYS SEP CYS GLN ALA NH2 HET SEP B 179 10 HET NH2 B 183 1 HET MG A 301 1 HET CL A 302 1 HET MG A 303 1 HET OQ3 A 304 15 HETNAM SEP PHOSPHOSERINE HETNAM NH2 AMINO GROUP HETNAM MG MAGNESIUM ION HETNAM CL CHLORIDE ION HETNAM OQ3 3-BROMANYL-5-METHANOYL-~{N}-METHYL-~{N}-(2- HETNAM 2 OQ3 SULFANYLETHYL)BENZAMIDE HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP C3 H8 N O6 P FORMUL 2 NH2 H2 N FORMUL 3 MG 2(MG 2+) FORMUL 4 CL CL 1- FORMUL 6 OQ3 C11 H12 BR N O2 S FORMUL 7 HOH *348(H2 O) HELIX 1 AA1 GLU A 2 ALA A 16 1 15 HELIX 2 AA2 ARG A 18 LYS A 32 1 15 HELIX 3 AA3 SER A 37 ASN A 70 1 34 HELIX 4 AA4 PRO A 79 SER A 105 1 27 HELIX 5 AA5 HIS A 106 ALA A 111 1 6 HELIX 6 AA6 ASP A 113 ALA A 135 1 23 HELIX 7 AA7 ASP A 139 MET A 162 1 24 HELIX 8 AA8 ASN A 166 ILE A 183 1 18 HELIX 9 AA9 SER A 186 LEU A 205 1 20 HELIX 10 AB1 HIS A 206 LEU A 208 5 3 HELIX 11 AB2 SER A 209 THR A 231 1 23 LINK NZ LYS A 122 C10 OQ3 A 304 1555 1555 1.43 LINK S1 OQ3 A 304 SG CYS B 180 1555 1555 2.02 LINK C LYS B 178 N SEP B 179 1555 1555 1.33 LINK C SEP B 179 N CYS B 180 1555 1555 1.32 LINK C ALA B 182 N NH2 B 183 1555 1555 1.33 LINK OE1 GLU A 35 MG MG A 303 1555 1555 2.63 LINK OE2 GLU A 35 MG MG A 303 1555 1555 2.35 LINK OE2 GLU A 75 MG MG A 301 1555 7445 2.21 LINK O GLU A 110 MG MG A 303 1555 1555 2.28 LINK O GLU A 161 MG MG A 301 1555 1555 2.27 LINK OE2 GLU A 188 MG MG A 303 1555 6455 2.41 LINK MG MG A 301 O HOH A 476 1555 1555 2.54 LINK MG MG A 301 O HOH A 513 1555 7455 2.27 LINK MG MG A 301 O HOH A 598 1555 1555 2.47 LINK MG MG A 303 O HOH A 495 1555 6454 2.33 LINK MG MG A 303 O HOH A 616 1555 1555 2.29 LINK MG MG A 303 O HOH A 617 1555 1555 2.35 CISPEP 1 SER A 105 HIS A 106 0 5.91 CRYST1 82.470 111.844 62.521 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012126 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008941 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015995 0.00000